U.S. Life Sciences Stock News

Recently, Matson’s shares formed a hammer candlestick pattern after a period of selling pressure, a technical signal often interpreted as potential support for the stock. At the same time, analysts have been raising their earnings estimates for Matson, suggesting improving confidence in the company’s profit outlook. Next, we’ll examine how the hammer pattern and rising earnings estimates may affect Matson’s investment narrative and perceived resilience. AI is about to change healthcare...

MGM Resorts International (MGM) just reported second quarter 2026 results, with higher net income and earnings per share from continuing operations compared with a year earlier, alongside a significant goodwill impairment charge. See our latest analysis for MGM Resorts International. MGM Resorts International shares trade at US$44.57 after easing 6.21% over the past month. However, the 90 day share price return of 15.77% and 1 year total shareholder return of 24.67% still point to improving...

Brookfield Infrastructure Partners L.P. recently reported its second-quarter 2026 results, with sales rising to US$6,482 million from US$5,429 million a year earlier, while posting a net loss of US$24 million and maintaining its regular quarterly distribution of US$0.455 per unit. Despite moving from a small profit to a loss over the first half of the year, Brookfield Infrastructure Partners continued to declare both common and preferred distributions, underlining management’s emphasis on...

Merck stock has more than doubled over the past five years, yet the latest valuation checks send a mixed message, with the Discounted Cash Flow (DCF) estimate pointing to meaningful upside while market based multiples look closer to in line. Merck has returned 101.7% over 5 years, which puts the current share price in a very different place to where long term holders started. Progress on products such as the once monthly HIV PrEP candidate alimatravir and expanded use of KEYTRUDA can support...

German American Bancorp, Inc. reported past second-quarter 2026 results showing net interest income of US$81.21 million and net income of US$38.17 million, alongside a regular quarterly dividend declaration of US$0.31 per share payable on August 20, 2026. An interesting insight for shareholders is that stronger earnings coincided with lower net charge-offs of US$673,000 compared with US$848,000 a year earlier, supporting the company’s dividend-paying capacity. We’ll now examine how German...

In late July 2026, Rush Street Interactive, Inc. reported second-quarter 2026 results showing sales of US$393.78 million, net income of US$11.55 million, and basic earnings per share from continuing operations of US$0.10, alongside higher six-month sales of US$764.14 million and net income of US$20.62 million compared with the prior year period. The company also raised its full-year 2026 revenue guidance to a range of US$1.56 billion to US$1.60 billion, highlighting confidence in online...

Smithfield Foods stock has gained 17.6% year to date, yet a fresh look at the numbers suggests the market price may still sit below what its cash flows imply. Both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to Smithfield Foods trading on the cheap side rather than fully priced. Year to date, Smithfield Foods is up 17.6%, which means recent buyers have already seen a solid return even before considering any valuation gap. The key support...

In July 2026, GE Vernova reported Q2 2026 results showing revenue of US$11,104 million and net income of US$668 million, with both basic and diluted earnings per share from continuing operations increasing versus a year earlier. Alongside this earnings release, the company disclosed it had completed a very large US$6,962.92 million share repurchase program that retired 4.57% of its shares, amplifying earnings per share growth. Next, we’ll consider how robust revenue growth alongside an...

TransMedics Group stock has more than doubled over the past five years, yet the broader valuation checks still lean cheap, which puts fresh attention on whether the recent pullback has gone too far or not far enough. Over the past five years, TransMedics Group has returned about 150.4% which keeps the long term story attractive even after a weaker recent stretch. Future execution on transplant system adoption can support higher earnings power. However, any slowdown in procedure volumes or...

Charter Communications stock is coming off a steep multi‑year slide, yet the broader valuation checks still suggest the shares lean cheap rather than expensive at current levels. Over the past 5 years the share price has declined about 81%, which puts a heavy focus on whether today’s lower valuation offers compensation for that drawdown. On the fundamental side, investor expectations around broadband subscriber trends and the pending Cox Communications acquisition can support the equity...

Deluxe has delivered a strong 75.2% return over the past year, yet the broader valuation checks still suggest the stock screens as cheap rather than stretched at the current US$25.87 share price. The 75.2% one year gain puts Deluxe among the stronger recent performers. This can raise the bar for what now counts as a reasonable entry price. The recently closed acquisition of Celero Commerce may support expectations for a larger payments platform, while the risk is that integration hurdles or...

Evercore (EVR) drew fresh attention on July 29, 2026 after reporting second quarter and first half earnings, alongside a new quarterly dividend declaration. This gave investors updated clues about profitability, revenue mix, and capital returns. See our latest analysis for Evercore. Evercore shares closed at US$320.56 on July 31, 2026, with the 1-day share price return of 2.46% coming after the latest earnings and dividend news. The 1-year total shareholder return of 10.17% sits against a...

CRISPR Therapeutics has delivered a steep share price decline of about 64.9% over the past 5 years, yet on broad valuation checks the stock now looks closer to fairly valued than like a clear bargain or clear bubble. The roughly 64.9% slide over 5 years highlights how much long term shareholders have given up in returns, which naturally raises the bar for any new investment case. Progress on CRISPR Therapeutics' allogeneic CAR-T programs, including the Phase 1 work on CTX112 aimed at off the...

InnovAge Holding (INNV) has filed a shelf registration for up to US$1.31 billion of common stock, covering 112,988,070 shares. This filing gives the company scope to raise equity capital when conditions appear suitable. See our latest analysis for InnovAge Holding. The shelf registration arrives after a strong period for InnovAge Holding, with the share price up 36.54% over 90 days and a year to date share price return of 118.88%. The 1 year total shareholder return of 262.94% points to...

Uranium Royalty Corp. recently reported full-year 2026 results showing sales of US$186.81 million and net income of US$40.25 million, and later filed a Form 15 to voluntarily deregister its common shares with the SEC under the Exchange Act. Together with the withdrawal of its CAD$150 million shelf registration and an upcoming CFO change, these actions point to a meaningful shift in how the company manages capital access and regulatory obligations. Next, we will examine how the strong...

In late July 2026, Western Alliance Bancorporation’s board declared a quarterly US$0.42 common dividend and a US$106.25 per share Series A preferred dividend alongside second-quarter results showing higher net interest income and net income than a year earlier. The combination of rising quarterly earnings, lower net loan charge-offs compared with the prior quarter, and continued share repurchases underpins a picture of active capital management and shareholder returns at the bank. We’ll now...

Stryker (SYK) has drawn fresh investor attention after reporting second quarter 2026 results, with sales of US$6.6b and net income of US$1.3b, alongside higher earnings per share from continuing operations. See our latest analysis for Stryker. The sharp 1 day share price decline of 6.42% to US$325.70 after Stryker’s earnings reflects investor focus on softer organic sales and ongoing supply disruptions, even though the 3 month share price return of 10.51% and 5 year total shareholder return...

KKR & Co. Inc. recently reported Q2 2026 net income of US$700.48 million, raised six‑month net income to US$1.11 billion year on year, affirmed a quarterly dividend of US$0.195 per share for August 2026, and expanded its infrastructure footprint through a US$16.00 billion Kuwait crude pipeline joint venture. The combination of stronger earnings per share and a long-duration, volume-tariff infrastructure partnership in Kuwait highlights KKR’s emphasis on fee-based, cash-generating assets...

Agree Realty earnings snapshot and what changed Agree Realty (ADC) just reported its second quarter and first half 2026 results, along with record investment activity, updated guidance for investment volume and AFFO per share, and a higher monthly dividend. The company reported second quarter revenue of US$205.1 million and net income of US$54.65 million, with diluted earnings per share from continuing operations of US$0.44 compared with US$0.43 a year earlier. For the first six months of...

Dutch Bros stock has delivered a strong 128.3% return over the past three years, yet the valuation checks currently lean expensive and suggest the recent share price near US$65.83 leaves less obvious room for error. Over the past three years, Dutch Bros has returned 128.3%, which puts extra focus on whether the current price still reflects a reasonable balance between growth expectations and risk. Expectations for continued store expansion and revenue growth can support a premium valuation...

Fresh conflict in the Middle East, rising energy prices and renewed inflation worries are shaking confidence in the 2026 stock market rally. For investors watching AI infrastructure enablers, that combination of higher costs and volatility can either pressure margins or create openings. This article looks at how the latest news links back to AI infrastructure related stocks, and why some could still look relatively well positioned while others may face tougher headwinds. The focus is on three...

Element Solutions Inc reported its second-quarter 2026 results, with sales rising to US$977.9 million from US$625.2 million and net income increasing to US$77.3 million from US$47.4 million, while a previously authorized buyback program saw no repurchases in the latest quarter but has cumulatively retired 63,734,799 shares for US$817.8 million since 2018. An interesting twist is that while quarterly revenue and earnings grew compared with a year earlier, net income for the first half of 2026...

Paylocity Holding stock has had a difficult run over the past five years, while current checks send mixed valuation signals, with the Discounted Cash Flow (DCF) intrinsic value pointing to a large gap to the current price and the market multiples implying the shares are not cheap. Paylocity Holding has declined 43.0% over five years, which raises the question of whether the current price reflects overly cautious expectations or ongoing concerns. New AI driven products such as Paylocity...

Neogen Corporation has released its fourth-quarter and full-year results for the period ended May 31, 2026, reporting revenue of US$225.3 million for the quarter and US$870.4 million for the year, alongside much lower net losses than the prior year despite slightly softer sales. The company also issued new fiscal 2027 revenue guidance of US$880 million to US$885 million, signaling management’s current expectations for stabilizing top-line performance after a year of modest revenue...